By using peptide-based strategies to inhibit anti-apoptotic proteins like BCL-2, programmed cell Demise is often induced in cancer cells, ultimately leading to their demise. These specific methodologies show encouraging leads to augmenting the efficiency of cancer therapy and boosting patient outcomes. Any likely conflicts of interest, for instance funding from https://joseonu123fdz1.blogsvila.com/profile